AGAPE ATP CORPORATION Increase (Decrease) in Contract with Customer, Liability
AGAPE ATP CORPORATION (ATPC) reported Increase (Decrease) in Contract with Customer, Liability of -$14.94 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-14
- AGAPE ATP CORPORATION increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$10.03K.
- AGAPE ATP CORPORATION increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$4.91K.
- AGAPE ATP CORPORATION increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $62.79K, a 596.99% increase year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $2.32K.
- AGAPE ATP CORPORATION increase (decrease) in contract with customer, liability for fiscal 2025 was $58.58K.
- AGAPE ATP CORPORATION increase (decrease) in contract with customer, liability for fiscal 2024 was -$7.34K.
- AGAPE ATP CORPORATION increase (decrease) in contract with customer, liability for fiscal 2023 was -$248.30K, a 361.71% decline from fiscal 2022.
- AGAPE ATP CORPORATION increase (decrease) in contract with customer, liability for fiscal 2022 was $94.88K, a 79.08% increase from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$10.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$14.94K 10-Q · filed 2026-08-14 | $47.85K derived: sum of 3 quarters · filed 2026-08-14 | $50.18K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$4.91K 10-Q · filed 2026-05-15 | $57.88K derived: sum of 2 quarters · filed 2026-05-15 | $60.21K derived: sum of 3 quarters · filed 2026-05-15 | $59.92K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $62.79K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $65.11K derived: sum of 2 quarters · filed 2026-04-13 | $64.83K derived: sum of 3 quarters · filed 2026-08-14 | $58.58K 10-K · filed 2026-04-13 | |
| 2025-09-30 | $2.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.04K derived: sum of 2 quarters · filed 2026-08-14 | -$4.21K 10-Q · filed 2025-11-13 | $4.80K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$287.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$6.53K 10-Q · filed 2026-08-14 | -$7.49K 10-Q · filed 2025-08-13 | $2.48K derived: sum of 3 quarters · filed 2026-08-14 | -$1.19K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$6.25K 10-Q · filed 2026-05-15 | $2.76K derived: sum of 2 quarters · filed 2026-05-15 | -$903.00 derived: sum of 3 quarters · filed 2026-05-15 | -$13.06K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $9.01K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $5.34K derived: sum of 2 quarters · filed 2026-04-13 | -$6.81K derived: sum of 3 quarters · filed 2026-04-13 | -$7.34K 10-K · filed 2026-04-13 | |
| 2024-09-30 | -$3.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$15.82K derived: sum of 2 quarters · filed 2025-11-13 | -$16.35K 10-Q · filed 2025-11-13 | -$219.56K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$12.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$12.68K 10-Q · filed 2025-08-13 | -$215.90K derived: sum of 3 quarters · filed 2025-08-13 | -$229.33K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$526.00 10-Q · filed 2025-05-15 | -$203.74K derived: sum of 2 quarters · filed 2025-05-15 | -$217.17K derived: sum of 3 quarters · filed 2025-05-15 | -$230.65K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$203.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$216.64K derived: sum of 2 quarters · filed 2025-03-31 | -$230.12K derived: sum of 3 quarters · filed 2025-03-31 | -$248.30K 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$13.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$26.91K derived: sum of 2 quarters · filed 2024-11-14 | -$45.08K 10-Q · filed 2024-11-14 | $247.31K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$13.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$31.66K 10-Q · filed 2024-08-14 | $260.74K derived: sum of 3 quarters · filed 2024-08-14 | $239.16K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$18.18K 10-Q · filed 2024-05-14 | $274.22K derived: sum of 2 quarters · filed 2024-05-14 | $252.64K derived: sum of 3 quarters · filed 2024-05-14 | $250.24K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $292.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $270.81K derived: sum of 2 quarters · filed 2024-04-01 | $268.42K derived: sum of 3 quarters · filed 2024-04-01 | $94.88K 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$21.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$23.98K derived: sum of 2 quarters · filed 2023-11-14 | -$197.52K 10-Q · filed 2023-11-14 | -$100.49K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$2.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$175.94K 10-Q · filed 2023-08-14 | -$78.91K derived: sum of 3 quarters · filed 2023-08-14 | -$62.34K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$173.54K 10-Q · filed 2023-05-15 | -$76.52K derived: sum of 2 quarters · filed 2023-05-15 | -$59.94K derived: sum of 3 quarters · filed 2023-05-15 | -$70.21K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $97.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $113.60K derived: sum of 2 quarters · filed 2023-03-31 | $103.33K derived: sum of 3 quarters · filed 2023-03-31 | $52.98K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $16.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $6.31K derived: sum of 2 quarters · filed 2022-11-14 | -$44.04K 10-Q · filed 2022-11-14 | -$197.44K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$10.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$60.62K 10-Q · filed 2022-08-11 | -$214.02K derived: sum of 3 quarters · filed 2022-08-11 | -$769.75K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$50.35K 10-Q · filed 2022-05-13 | -$203.75K derived: sum of 2 quarters · filed 2022-07-05 | -$759.49K derived: sum of 3 quarters · filed 2022-07-05 | ||
| 2020-12-31 | -$153.40K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | -$709.14K derived: sum of 2 quarters · filed 2022-07-05 | -$1.42M 10-K/A · filed 2022-07-05 | ||
| 2020-09-30 | -$555.74K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | -$1.27M 10-Q/A · filed 2022-07-05 | |||
| 2020-06-30 | -$712.75K 10-Q · filed 2021-08-13 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | -$77.42K derived: sum of 3 quarters · filed 2021-03-31 | -$217.74K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$77.42K derived: sum of 2 quarters · filed 2020-11-16 | -$217.74K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | -$77.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$217.74K 10-Q · filed 2020-08-13 | |||
| 2019-03-31 | -$140.32K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |